Is AcelRx Pharmaceuticals Inc (ACRX) A Good Stock To Buy?
With the first-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred......(read more)
Posts Tagged ‘NASDAQ:ACRX’
Hedge Funds Have Never Been More Bullish On AcelRx Pharmaceuticals Inc (ACRX)
Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions......(read more)
Hedge Funds Are Crazy About AcelRx Pharmaceuticals Inc (ACRX)
Amid an overall market correction, many stocks that smart money investors were collectively bullish on tanked during the fourth quarter. Among them, Amazon......(read more)
Does AcelRx Pharmaceuticals Inc (ACRX) Stack Up Against Its Peers?
The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil......(read more)
McDonald’s Corporation (MCD), AcelRx Pharmaceuticals Inc. (ACRX) & More: Here’s Why These Stocks Are Trending Today
The US stock market is trading higher today as investors remain on the sidelines ahead of the Federal Reserve’s monetary policy meeting next week.......(read more)
Should You Avoid AcelRx Pharmaceuticals Inc (ACRX)?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours......(read more)
Why Is Joseph Edelman’s Hedge Fund So Bullish On AcelRx?
In a disclosure of its holdings, Joseph Edelman’s Perceptive Advisors made public that it currently owns 6.57 million shares of AcelRx Pharmaceuticals......(read more)
Joseph Edelman, Perceptive Advisors Continue Bullish Streak in AcelRX Pharmaceuticals
Joseph Edelman’s fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position......(read more)
Joseph Edelman’s Perceptive Advisors Buys More AcelRx Pharmaceuticals
Joseph Edelman‘s fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again,......(read more)
Joseph Edelman and Perceptive Advisors Buy 360,700 Shares of AcelRx Pharmaceuticals
Hedge fund Perceptive Advisors, founded and managed by Joseph Edelman, increased its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) by some 360......(read more)
AcelRx Pharmaceuticals Inc (ACRX): Long-Term Growth With Biotech Innovators
The global biotechnology industry is expected to reach $320 billion by 2015, up from $232 billion in 2012. Improving healthcare infrastructure and focus......(read more)
AcelRx Pharmaceuticals Inc (ACRX): Insiders Are Buying, Should You?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) a first-rate investment today? Hedge funds are getting less optimistic. The number of long hedge fund bets......(read more)
Hedge Funds Are Betting On Horizon Pharma Inc (HZNP)
Is Horizon Pharma Inc (NASDAQ:HZNP) going to take off soon? Money managers are turning bullish. The number of long hedge fund bets improved by 1 recently......(read more)
AcelRx Pharmaceuticals Inc (ACRX), Peregrine Pharmaceuticals (PPHM): This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
AcelRx Pharmaceuticals Inc (ACRX): Hedge Funds and Insiders Are Bullish, What Should You Do?
Is AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) the right investment to pursue these days? Investors who are in the know are in an optimistic mood. The number......(read more)
Hedge Funds Are Crazy About Zogenix, Inc. (ZGNX)
Is Zogenix, Inc. (NASDAQ:ZGNX) a healthy stock for your portfolio? Hedge funds are betting on the stock. The number of long hedge fund positions rose......(read more)
Horizon Pharma Inc (HZNP): Insiders Are Dumping, Should You?
Horizon Pharma Inc (NASDAQ:HZNP) has seen a decrease in activity from the world’s largest hedge funds of late. According to most shareholders, hedge......(read more)
ACADIA Pharmaceuticals Inc. (ACAD), Astex Pharmaceuticals, Inc. (ASTX), Pfizer Inc. (PFE), and More: This Week in Biotech
With the SPDR S&P Biotech Index up 35% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
